|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
CA2008368C
(en)
|
1989-01-24 |
2003-04-08 |
Jeffrey Greve |
Soluble molecule related to but distinct from icam-1
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
MXPA04009728A
(es)
|
2002-04-05 |
2005-06-08 |
Agenysys Inc |
Acido nucleico y proteina correspondiente titulada 98p4b6 en el tratamiento y deteccion del cancer.
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
WO2005079490A2
(en)
|
2004-02-13 |
2005-09-01 |
Nuvelo, Inc. |
Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides
|
|
TW200539855A
(en)
|
2004-03-15 |
2005-12-16 |
Wyeth Corp |
Calicheamicin conjugates
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
US20080305044A1
(en)
|
2004-11-29 |
2008-12-11 |
Seattle Genetics, Inc. |
Engineered Antibodies and Immunoconjugates
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
RU2448979C2
(ru)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Антитела человека к дельта-подобному лиганду-4 человека
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
US7985557B2
(en)
|
2007-05-23 |
2011-07-26 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
UA108598C2
(xx)
|
2008-04-30 |
2015-05-25 |
|
Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
|
|
ES2560807T3
(es)
|
2008-07-21 |
2016-02-22 |
Polytherics Limited |
Nuevos reactivos y procedimiento de conjugación de moléculas biológicas
|
|
JO3182B1
(ar)
|
2009-07-29 |
2018-03-08 |
Regeneron Pharma |
مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
|
|
DK2889624T3
(en)
|
2009-08-10 |
2018-12-10 |
Ucl Business Plc |
Reversible covalent bonding of functional molecules
|
|
PT2528625E
(pt)
|
2010-04-15 |
2013-10-17 |
Spirogen Sarl |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
EP2601298B1
(en)
|
2010-08-02 |
2016-11-30 |
Regeneron Pharmaceuticals, Inc. |
Mice that make binding proteins comprising vl domains
|
|
DK2714685T3
(en)
|
2011-05-27 |
2017-01-09 |
Ambrx Inc |
FORMATIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID BOUND dolastatin
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
AU2012322934B2
(en)
|
2011-10-14 |
2016-09-08 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
JP6166728B2
(ja)
|
2011-10-14 |
2017-07-19 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピンの製造に有用な合成方法及び中間体
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
BR112014013526A8
(pt)
|
2011-12-05 |
2017-06-13 |
Igenica Biotherapeutics Inc |
conjugados de anticorpo-fármaco e compostos, composições e métodos relacionados
|
|
RU2582259C2
(ru)
*
|
2012-02-24 |
2016-04-20 |
Алтеоген Инк. |
Модифицированные антитела, с которыми связан мотив, включающий остаток цистеина, конъюгаты этих модифицированных антител с лекарственными веществами и способ их получения
|
|
US8569554B1
(en)
*
|
2012-07-12 |
2013-10-29 |
Primus Green Energy Inc |
Fuel composition
|
|
US10195288B2
(en)
*
|
2012-10-11 |
2019-02-05 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate
|
|
HRP20180268T4
(hr)
|
2012-10-23 |
2026-03-27 |
Synaffix B.V. |
Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
|
|
KR20160042871A
(ko)
*
|
2013-06-21 |
2016-04-20 |
이나뜨 파르마, 에스.아. |
폴리펩티드의 효소적 콘쥬게이션
|
|
AU2014311361B2
(en)
|
2013-08-26 |
2018-11-29 |
Regeneron Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
|
|
SG11201603960XA
(en)
*
|
2014-01-31 |
2016-07-28 |
Daiichi Sankyo Co Ltd |
Anti-her2 antibody-drug conjugate
|
|
JP2017114763A
(ja)
*
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗ｃｄ９８抗体−薬物コンジュゲート
|
|
TWI871999B
(zh)
*
|
2014-04-10 |
2025-02-01 |
日商第一三共股份有限公司 |
抗her3抗體-藥物結合物
|
|
WO2015187596A2
(en)
|
2014-06-02 |
2015-12-10 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
MA42971A
(fr)
|
2015-03-13 |
2018-08-15 |
Cytomx Therapeutics Inc |
Anticorps anti-pdl1, anticorps anti-pld1 activables, et leurs procédés d'utilisation
|
|
KR101757977B1
(ko)
|
2015-06-26 |
2017-07-13 |
아주대학교산학협력단 |
바이오 잉크의 제조방법 및 3d 프린터 적용
|
|
MX390630B
(es)
|
2016-01-25 |
2025-03-21 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos y metodos de uso.
|
|
EP3419670A2
(en)
|
2016-02-26 |
2019-01-02 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
KR102520731B1
(ko)
|
2016-09-23 |
2023-04-14 |
리제너론 파아마슈티컬스, 인크. |
항-steap2 항체, 항체-약물 컨쥬게이트, 및 steap2 및 cd3에 결합하는 이중특이적 항원-결합 분자, 및 이의 용도
|
|
CA3042428A1
(en)
|
2016-11-08 |
2018-05-17 |
Regeneron Pharmaceuticals, Inc. |
Steroids and protein-conjugates thereof
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
WO2018182341A1
(ko)
|
2017-03-29 |
2018-10-04 |
주식회사 레고켐 바이오사이언스 |
피롤로벤조디아제핀 이량체 전구체 및 이의 리간드-링커 접합체 화합물
|
|
EP3625209A1
(en)
*
|
2017-05-18 |
2020-03-25 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
EP3630189A4
(en)
|
2017-05-24 |
2021-06-23 |
The Board of Regents of The University of Texas System |
LINKER FOR ANTIBODY MEDICINAL CONJUGATES
|
|
TWI804499B
(zh)
*
|
2017-06-23 |
2023-06-11 |
美商維洛斯生物公司 |
Ror1抗體免疫接合物
|
|
EP3700577A1
(en)
|
2017-10-23 |
2020-09-02 |
Mablink Bioscience |
Ligand-drug-conjugate comprising a single molecular weight polysarcosine
|
|
JP7328990B2
(ja)
|
2018-04-30 |
2023-08-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｈｅｒ２及び／またはａｐｌｐ２に結合する抗体及び二重特異性抗原結合分子、ならびにそれらのコンジュゲート及び使用
|
|
WO2019217591A1
(en)
*
|
2018-05-09 |
2019-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-msr1 antibodies and methods of use thereof
|
|
EP3794042B1
(en)
*
|
2018-05-18 |
2024-03-27 |
Daiichi Sankyo Co., Ltd. |
Anti-muc1- exatecan antibody-drug conjugate
|
|
BR112021001750A2
(pt)
|
2018-08-06 |
2021-04-27 |
Daiichi Sankyo Company, Limited |
composição farmacêutica
|
|
UA130338C2
(uk)
|
2018-09-26 |
2026-01-28 |
Джянгсу Хенгруй Медісін Ко., Лтд. |
Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування
|
|
CA3120528A1
(en)
|
2018-11-20 |
2020-05-28 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
WO2020180893A1
(en)
*
|
2019-03-04 |
2020-09-10 |
Cloudmode Corp. |
Systems and methods for tracking and authorizing usage of a vaporizer using digital facial recognition
|
|
CN111752338B
(zh)
*
|
2019-03-27 |
2024-09-24 |
华为技术有限公司 |
一种间歇抬升组件及移动终端
|
|
CN109976614B
(zh)
*
|
2019-03-28 |
2021-04-06 |
广州视源电子科技股份有限公司 |
一种立体图形的标注方法、装置、设备及介质
|
|
FR3094220B1
(fr)
*
|
2019-03-29 |
2022-02-25 |
Chanel Parfums Beaute |
Composition cosmétique filmogène pelable
|
|
EP3976112A1
(en)
|
2019-06-03 |
2022-04-06 |
Synaffix B.V. |
Acetal-based cleavable linkers
|
|
CN110974975B
(zh)
|
2019-12-12 |
2023-10-20 |
成都百利多特生物药业有限责任公司 |
一种快速释放的抗体药物偶联物
|
|
CA3166619A1
(en)
|
2020-02-28 |
2021-09-02 |
Julian Andreev |
Bispecific antigen binding molecules that bind her2, and methods of use thereof
|
|
CN115103691B
(zh)
|
2020-03-25 |
2025-01-24 |
苏州盛迪亚生物医药有限公司 |
一种含抗体药物偶联物的药物组合物及其用途
|
|
US12605459B2
(en)
|
2020-07-13 |
2026-04-21 |
Regeneron Pharmaceuticals, Inc. |
Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
|
|
US20250122282A2
(en)
|
2020-09-04 |
2025-04-17 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
|
EP4227310A4
(en)
|
2020-10-12 |
2024-11-06 |
Sichuan Baili Pharmaceutical Co. Ltd. |
CAMPTOTHECIN DERIVATIVE AND LIGAND-DRUG CONJUGATE THEREOF
|
|
MX2023011630A
(es)
|
2021-03-30 |
2024-01-24 |
Mablink Bioscience |
Enlace autorreactivo activado por enzima que tiene propiedades fisicoquimicas y farmacologicas mejoradas.
|
|
WO2022204947A1
(zh)
|
2021-03-30 |
2022-10-06 |
上海复旦张江生物医药股份有限公司 |
一种连接基药物偶联物的制备方法及其中间体
|
|
AU2022269073A1
(en)
|
2021-05-07 |
2023-11-23 |
ALX Oncology Inc. |
Exatecan derivatives and antibody-drug conjugates thereof
|
|
MX2023012920A
(es)
|
2021-06-02 |
2023-11-13 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Conjugado anticuerpo-farmaco y metodo de preparacion y uso del mismo.
|
|
CN117500528A
(zh)
|
2021-06-18 |
2024-02-02 |
北京海步医药科技有限公司 |
连接子及其缀合物
|
|
EP4460330A1
(en)
|
2022-01-06 |
2024-11-13 |
Virtuoso Binco, Inc. |
Conjugates, compositions and methods of use
|
|
MX2024008640A
(es)
|
2022-01-12 |
2024-07-24 |
Regeneron Pharma |
Analogos de camptotecina conjugados a un residuo de glutamina en una proteina y su uso.
|
|
KR20240150807A
(ko)
|
2022-02-22 |
2024-10-16 |
아라리스 바이오테크 아게 |
2개 이상의 페이로드를 포함하는 펩티드 링커
|
|
JP2025519421A
(ja)
|
2022-06-09 |
2025-06-26 |
ベイジーン スイッツァランド ゲーエムベーハー |
抗体薬物複合体
|